Marine Compound Discovery Shows Promise of Improved Drug Treatment for COPD Patients

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.

Related Articles
ADHD medications are prone to the same abuse, misuse, and diversion as opioids.
Enterovirus-D68 could soon be in the rearview mirror, according to a Hartford, CT, pediatric intensivist who has treated more than 20 children hospitalized with the infection.
Influenza boosts the ability of pneumococci to cause middle ear and throat infections.
Latest Issues
$auto_registration$